Search Stock:
Gland Pharma Share Price, Technical, Fundamental Analysis, Financials, Shareholding, RSI, MACD and Moving Averages
Price on NSE
Price on BSE
Gland Pharma (GLAND (Bse Code: 543245)) Key Ratios
P/E
Company42.46
Sector7.4
A Price-to-Earnings of 42.46 means investors pay 42.46 units per 1 unit of earnings. This is higher than the sector average of 7.4.
P/B
Company4.63
Sector4.36
A P/B ratio of 4.63 shows market value relative to book value. This is higher than the sector average of 4.36.
ROA
Company9.02%
Sector-17.84%
Return on Assets shows a 9.02% profit per unit of asset. This is lower than the sector average of -17.84%.
ROE
Company9.92%
Sector-2.58%
Return on Equity creates 9.92% profit per unit of equity. This is higher than the sector average of -2.58%.
ROCE
Company14.02%
Sector6.43%
ROCE indicates 14.02% operating earnings per unit of capital. This is higher than the sector average of 6.43%.
Quick Ratio
Company3.6
Sector6.85
The Quick Ratio is 3.6 compared to sector average 6.85.
EV/EBITDA
Company21.26
Sector14.92
EV/EBITDA of 21.26 means value is 21.26 times core earnings. This is higher than the sector average of 14.92.
Gland Pharma Share Price Analysis Local DB
Gland Pharma share price is ₹2,868.40, day high (share price) is ₹2,930.00, day low (share price) is ₹2,803.00 and volume is 556,481. 52 Week high share price for Gland Pharma is ₹3,039.80 on 14 Aug 2026 and 52 week low share price for Gland Pharma is ₹1,573.60 on 16 Mar 2026. Price data as of: 02 Sep, 2026 3:31 PM.
According to latest price data (as of 02 Sep, 2026 3:31 PM) for Gland Pharma share, 14 day period RSI (Relative Strength Index) is 61.9, 50 DMA (50 Displaced Moving Average) is 2,615.95 and 200 DMA (200 Displaced Moving Average) is 2,032.76.
▼
₹2,868.40
-6.60 (-0.23%)
As of 02 Sep, 2026
Open
₹2,915.00
Day High - Low
₹2,930.00 - ₹2,803.00
Volume
556,481
52 Weeks High
₹3,039.80
on 14 Aug 2026
52 Weeks Low
₹1,573.60
on 16 Mar 2026
RSI (14)
61.9
50 DMA
2,615.95
200 DMA
2,032.76
Loading...
Gland Pharma (GLAND) Technical Analysis
₹2,868.40
-6.60
02 Sep, 2026
Gland Pharma Technical Data and Analysis available in multiple timeframes.
Gland Pharma Oscillators Analysis
On the Day timeframe, the outlook for GLAND is: The long-term trend is Positive (Price vs 200 SMA) and RSI (14) is: 61.9.
Gland Pharma Price Action
Gland Pharma Oscillators Overview
| Indicator | Value |
|---|---|
| RSI (14) | 61.94 |
| Stoch %K (14, 3, 3) | 38.04 |
| CCI (20) | 24.89 |
| ADX (14) | 40.54 |
| Awesome Osc | 190.32 |
| Momentum (10) | 27.10 |
| MACD (12, 26, 9) | 82.24 |
| MACD Signal | 94.80 |
| Stoch RSI (14) | 15.31 |
| Williams %R (14) | -65.00 |
| Bull/Bear Power | 38.48 |
| Ultimate Osc | 51.73 |
| MFI (14) | 37.18 |
| ROC (21) | 11.04 |
| ROC (125) | 57.41 |
| ATR (14) | 86.18 |
Gland Pharma Moving Averages
GLAND is trading above 13 out of 14 SMAs.
2,868.40
CURRENT PRICE
Bullish Moving Averages
13
Bearish Moving Averages
1
5 SMA2,878.14
8 SMA2,865.01
9 SMA2,859.93
10 SMA2,855.94
12 SMA2,854.94
20 SMA2,839.98
21 SMA2,825.93
26 SMA2,771.94
30 SMA2,722.78
34 SMA2,691.56
50 SMA2,615.95
100 SMA2,326.80
150 SMA2,136.43
200 SMA2,032.76
| Ichimoku Base | 2,734.25 | Above Base |
| VWMA (20) | 2,883.30 | Below VWMA |
| HMA (9) | 2,888.81 | Below HMA |
Gland Pharma Technical SWOT Analysis
STRENGTHS
- Price is trading above the 200 DMA, indicating relatively stronger long-term positioning.
- Price is above the 50 DMA, suggesting supportive medium-term trend structure.
- RSI at 61.94 indicates relatively strong momentum without being overbought.
WEAKNESSES
- No notable technical weakness signals are currently observed.
OPPORTUNITIES
- No specific opportunity signals are identified; the setup appears neutral.
THREATS
- No immediate technical risk signals are identified.
Gland Pharma Daily Pivot Points (Support & Resistance)
| Level | Classic | Woodie's | Camarilla | Fibonacci |
|---|---|---|---|---|
| Resistance 3 | 2,985.27 | 3,018.95 | 2,894.06 | 2,956.93 |
| Resistance 2 | 2,956.93 | 2,973.78 | 2,887.71 | 2,930.46 |
| Resistance 1 | 2,915.97 | 2,949.65 | 2,881.35 | 2,914.11 |
| Pivot Point | 2,887.63 | 2,904.48 | 2,875.00 | 2,887.63 |
| Support 1 | 2,846.67 | 2,880.35 | 2,868.65 | 2,861.16 |
| Support 2 | 2,818.33 | 2,835.18 | 2,862.30 | 2,844.81 |
| Support 3 | 2,777.37 | 2,811.05 | 2,855.94 | 2,818.33 |
Records:
| Date | Close | ADX | PDI | MDI | Aroon Up | Aroon Down | Bollinger UB | Bollinger MB | Bollinger LB | CCI | CMF | MACD | Signal | MFI | PSAR | RSI (F) | RSI | Sto (F) %K | %D | Supertrend | Ult Osc | Wil %R |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing oscillators history... | ||||||||||||||||||||||
Records:
| Date | Close | SMA(5) | EMA(5) | SMA(8) | EMA(8) | SMA(9) | EMA(9) | SMA(10) | EMA(10) | SMA(12) | EMA(12) | SMA(20) | EMA(20) | SMA(21) | EMA(21) | SMA(26) | EMA(26) | SMA(30) | EMA(30) | SMA(34) | EMA(34) | SMA(50) | EMA(50) | SMA(100) | EMA(100) | SMA(150) | EMA(150) | SMA(200) | EMA(200) | Ichimoku Base | VWMA(20) | HMA(9) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synchronizing moving averages history... | ||||||||||||||||||||||||||||||||
Gland Pharma - Shareholding Pattern
Historical breakdown of ownership percentages over time.
| Category | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Promoters | 51.77% | 51.83% | 51.83% | 51.83% |
| FII | 8.74% | 7.30% | 7.58% | 7.91% |
| DII (Other) | 2.21% | 1.58% | 1.57% | 2.45% |
| Retail & Others | 9.05% | 7.52% | 7.61% | 7.63% |
| Mutual Funds | 28.23% | 31.78% | 31.42% | 30.19% |
Gland Pharma - Yearly Income Statement (in ₹ Crore)
| Period | Revenue | Operating Profit | Net Profit |
|---|---|---|---|
| Mar 2026 | 6,746.98 +15.73% | 1,464.58 +37.82% | 1,027.32 +47.07% |
| Mar 2025 | 5,830.11 -0.08% | 1,062.66 -6.17% | 698.53 -9.57% |
| Mar 2024 | 5,834.96 +50.97% | 1,132.54 +7.39% | 772.46 -1.1% |
| Mar 2023 | 3,865.06 | 1,054.58 | 781.04 |
Gland Pharma - Corporate Actions
| Type | Ex-Date | Amount / Ratio | Details |
|---|---|---|---|
| Dividend | 14 Aug 2025 | ₹18 | View Details |
|
Announcement date
20 May 2025
Ex dividend date
14 Aug 2025
Record date
14 Aug 2025
Dividend type
Final
Amount
18.0
Dividend %
1800.0
Details
Rs.18.0000 per share(1800%)Final Dividend
|
|||
Gland Pharma Share Price and Volume Historical Data
Synchronizing MarketBandhu Database...
